vs

Side-by-side financial comparison of Beacon Financial Corp (BBT) and CORCEPT THERAPEUTICS INC (CORT). Click either name above to swap in a different company.

Beacon Financial Corp is the larger business by last-quarter revenue ($216.7M vs $202.1M, roughly 1.1× CORCEPT THERAPEUTICS INC). Beacon Financial Corp runs the higher net margin — 24.6% vs 12.0%, a 12.6% gap on every dollar of revenue. Over the past eight quarters, Beacon Financial Corp's revenue compounded faster (41.2% CAGR vs 17.3%).

Beacon Roofing Supply, Inc. is an American company which sells residential and non-residential roofing products, as well as related building products in North America. As of December 31, 2023, the company had 533 locations throughout all 50 states in the U.S. and six Canadian provinces, and over 8,000 employees. In addition to roofing, local divisions may also sell windows, siding, decking, waterproofing and other external building products. The company is currently headquartered in Herndon, ...

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

BBT vs CORT — Head-to-Head

Bigger by revenue
BBT
BBT
1.1× larger
BBT
$216.7M
$202.1M
CORT
Higher net margin
BBT
BBT
12.6% more per $
BBT
24.6%
12.0%
CORT
Faster 2-yr revenue CAGR
BBT
BBT
Annualised
BBT
41.2%
17.3%
CORT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BBT
BBT
CORT
CORT
Revenue
$216.7M
$202.1M
Net Profit
$53.4M
$24.3M
Gross Margin
98.7%
Operating Margin
2.2%
Net Margin
24.6%
12.0%
Revenue YoY
11.1%
Net Profit YoY
179.4%
-21.0%
EPS (diluted)
$0.55
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BBT
BBT
CORT
CORT
Q1 26
$216.7M
Q4 25
$225.7M
$202.1M
Q3 25
$141.2M
$207.6M
Q2 25
$113.7M
$194.4M
Q1 25
$110.4M
$157.2M
Q4 24
$110.2M
$181.9M
Q3 24
$125.6M
$182.5M
Q2 24
$108.7M
$163.8M
Net Profit
BBT
BBT
CORT
CORT
Q1 26
$53.4M
Q4 25
$53.4M
$24.3M
Q3 25
$-4.2M
$19.7M
Q2 25
$22.0M
$35.1M
Q1 25
$19.1M
$20.5M
Q4 24
$17.5M
$30.7M
Q3 24
$20.1M
$47.2M
Q2 24
$16.4M
$35.5M
Gross Margin
BBT
BBT
CORT
CORT
Q1 26
Q4 25
98.7%
Q3 25
97.8%
Q2 25
98.2%
Q1 25
98.5%
Q4 24
98.4%
Q3 24
98.4%
Q2 24
98.5%
Operating Margin
BBT
BBT
CORT
CORT
Q1 26
Q4 25
2.2%
Q3 25
-5.9%
4.9%
Q2 25
26.0%
13.7%
Q1 25
23.1%
2.2%
Q4 24
21.6%
13.9%
Q3 24
21.3%
25.5%
Q2 24
19.9%
21.7%
Net Margin
BBT
BBT
CORT
CORT
Q1 26
24.6%
Q4 25
23.6%
12.0%
Q3 25
-3.0%
9.5%
Q2 25
19.4%
18.1%
Q1 25
17.3%
13.1%
Q4 24
15.9%
16.9%
Q3 24
16.0%
25.9%
Q2 24
15.1%
21.7%
EPS (diluted)
BBT
BBT
CORT
CORT
Q1 26
$0.55
Q4 25
$0.64
$0.20
Q3 25
$-0.05
$0.16
Q2 25
$0.25
$0.29
Q1 25
$0.21
$0.17
Q4 24
$0.20
$0.25
Q3 24
$0.23
$0.41
Q2 24
$0.18
$0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BBT
BBT
CORT
CORT
Cash + ST InvestmentsLiquidity on hand
$927.3M
$372.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.5B
$647.8M
Total Assets
$22.2B
$836.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BBT
BBT
CORT
CORT
Q1 26
$927.3M
Q4 25
$1.8B
$372.2M
Q3 25
$1.2B
$421.7M
Q2 25
$342.2M
Q1 25
$322.8M
Q4 24
$543.7M
$383.3M
Q3 24
$380.3M
Q2 24
$473.2M
Total Debt
BBT
BBT
CORT
CORT
Q1 26
Q4 25
Q3 25
$1.1B
Q2 25
$225.6M
Q1 25
$284.6M
Q4 24
$1.5B
Q3 24
$353.6M
Q2 24
$278.6M
Stockholders' Equity
BBT
BBT
CORT
CORT
Q1 26
$2.5B
Q4 25
$2.5B
$647.8M
Q3 25
$2.4B
$631.9M
Q2 25
$1.3B
$635.8M
Q1 25
$1.2B
$683.3M
Q4 24
$1.2B
$679.6M
Q3 24
$1.2B
$638.8M
Q2 24
$1.2B
$596.2M
Total Assets
BBT
BBT
CORT
CORT
Q1 26
$22.2B
Q4 25
$23.2B
$836.7M
Q3 25
$22.8B
$823.6M
Q2 25
$12.0B
$801.7M
Q1 25
$12.0B
$846.5M
Q4 24
$11.9B
$840.6M
Q3 24
$11.6B
$784.3M
Q2 24
$12.2B
$714.6M
Debt / Equity
BBT
BBT
CORT
CORT
Q1 26
Q4 25
Q3 25
0.45×
Q2 25
0.18×
Q1 25
0.24×
Q4 24
1.24×
Q3 24
0.29×
Q2 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BBT
BBT
CORT
CORT
Operating Cash FlowLast quarter
$38.4M
Free Cash FlowOCF − Capex
$38.4M
FCF MarginFCF / Revenue
19.0%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.58×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BBT
BBT
CORT
CORT
Q1 26
Q4 25
$38.4M
Q3 25
$-4.8M
$54.5M
Q2 25
$38.5M
$43.9M
Q1 25
$23.3M
$5.1M
Q4 24
$105.0M
$59.3M
Q3 24
$19.9M
$73.8M
Q2 24
$34.8M
$41.2M
Free Cash Flow
BBT
BBT
CORT
CORT
Q1 26
Q4 25
$38.4M
Q3 25
$-5.9M
Q2 25
$36.3M
$43.9M
Q1 25
$19.9M
$5.0M
Q4 24
$100.0M
$59.2M
Q3 24
$17.2M
$72.2M
Q2 24
$34.4M
$40.8M
FCF Margin
BBT
BBT
CORT
CORT
Q1 26
Q4 25
19.0%
Q3 25
-4.2%
Q2 25
31.9%
22.6%
Q1 25
18.0%
3.2%
Q4 24
90.7%
32.5%
Q3 24
13.7%
39.5%
Q2 24
31.7%
24.9%
Capex Intensity
BBT
BBT
CORT
CORT
Q1 26
Q4 25
0.0%
Q3 25
0.8%
0.0%
Q2 25
1.9%
0.0%
Q1 25
3.1%
0.1%
Q4 24
4.5%
0.1%
Q3 24
2.1%
0.9%
Q2 24
0.3%
0.3%
Cash Conversion
BBT
BBT
CORT
CORT
Q1 26
Q4 25
1.58×
Q3 25
2.77×
Q2 25
1.75×
1.25×
Q1 25
1.22×
0.25×
Q4 24
5.99×
1.93×
Q3 24
0.99×
1.56×
Q2 24
2.12×
1.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BBT
BBT

Net Interest Income$190.8M88%
Noninterest Income$25.9M12%

CORT
CORT

Segment breakdown not available.

Related Comparisons